Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 04-2005 | 01-2005 | 10-2004 | 07-2004 | 04-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,285 | 4,925 | 968 | N/A | 3,077 |
| Depreciation Amortization | 26 | 18 | 9 | N/A | 45 |
| Accounts receivable | -2,237 | -1,147 | -199 | N/A | 272 |
| Other Working Capital | 3,515 | 3,270 | 1,544 | N/A | -108 |
| Other Operating Activity | 1,711 | 522 | -454 | 0 | -390 |
| Operating Cash Flow | $8,299 | $7,589 | $1,868 | $N/A | $2,895 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -31 | -31 | -21 | N/A | -2 |
| Other Investing Activity | 528 | 335 | 155 | 0 | 255 |
| Investing Cash Flow | $496 | $304 | $133 | $N/A | $253 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,495 | 1,934 | 352 | N/A | 27 |
| Other Financing Activity | -46 | 0 | 0 | 0 | -196 |
| Financing Cash Flow | $3,450 | $1,934 | $352 | $N/A | $-169 |
| Beginning Cash Position | 4,310 | 4,310 | 4,310 | N/A | 1,504 |
| End Cash Position | 16,555 | 14,136 | 6,663 | N/A | 4,484 |
| Net Cash Flow | $12,246 | $9,827 | $2,353 | $N/A | $2,980 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,299 | 7,589 | 1,868 | N/A | 2,895 |
| Capital Expenditure | -31 | -31 | -21 | N/A | -2 |
| Free Cash Flow | 8,268 | 7,558 | 1,846 | 0 | 2,893 |